2001
DOI: 10.1097/00005373-200111000-00018
|View full text |Cite
|
Sign up to set email alerts
|

Trans-Sodium Crocetinate Restores Blood Pressure, Heart Rate, and Plasma Lactate after Hemorrhagic Shock

Abstract: It would appear that TSC is a promising initial treatment for hemorrhagic shock.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1

Citation Types

1
12
0

Year Published

2003
2003
2010
2010

Publication Types

Select...
5
1
1

Relationship

1
6

Authors

Journals

citations
Cited by 24 publications
(13 citation statements)
references
References 20 publications
1
12
0
Order By: Relevance
“…kg-I). This dose is higher than the threshold dose of 0.1-0.2 mg' kg-1 and lower than the maximum tested without deleterious side effects (24).…”
Section: Drug Treatmentsmentioning
confidence: 67%
See 3 more Smart Citations
“…kg-I). This dose is higher than the threshold dose of 0.1-0.2 mg' kg-1 and lower than the maximum tested without deleterious side effects (24).…”
Section: Drug Treatmentsmentioning
confidence: 67%
“…Although TSC has not been extensively studied, crocetin has been examined in a number of 02-related experiments and was shown to increase O 2 diffusivity through plasma by 30% (23). Unlike fluoro carbons or hemoglobin, crocetin does not bind O 2 or in crease its solubility in blood plasma but increases O 2 consumption during hemorrhagic shock (24). TSC in creased mean arterial blood pressure immediately and reduced tachycardia in a rat model of hemorrhagic shock (24).…”
Section: Transsodium Crocetinate (Tsc)mentioning
confidence: 97%
See 2 more Smart Citations
“…From this point on, only TSC was used in our studies and most of the subsequent studies involved the effect of bolus injections of TSC on blood pressure, heart effect of a rate, blood acidosis and liver enzymes (3,4). First, the single bolus of TSC with no subsequent saline infusion being given was studied.…”
mentioning
confidence: 99%